About
Preclinical In-Vivo Alzheimer's Contract Research
Areas of Focus
Categories
Contract ResearchContract ResearchContract Research
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
743
By Phase
PHASE1: 2PHASE2: 1
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07016464Lead Sponsor
A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.
PHASE1Active, not recruiting
52 participants
Started: Mar 20, 2025 · Completed: Mar 29, 2026
NCT05478031Lead Sponsor
A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease
PHASE2Terminated
14 participants
Started: Jun 7, 2022 · Completed: Jun 4, 2024
NCT04672135Lead Sponsor
A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127
PHASE1Completed
77 participants
Started: Nov 9, 2020 · Completed: Apr 26, 2022
NCT00245284Lead Sponsor
Predictor of Advanced Subclinical Atherosclerosis
N/ACompleted
600 participants
Started: Sep 30, 2005 · Completed: May 31, 2006
Locations (1)
Headquarters
Leuven, Belgium
Map
Loading map...